Figure
1.1. Signaling Pathway Activation
Figure 1.2. The Human Kinome
Figure 1.3. Mechanisms of Activation of Normal Tyrosine Kinases
Table 2.1. Receptor Tyrosine Kinase Inhibitors in Clinical Trials
Table 2.2. Non-receptor Tyrosine Kinase Inhibitors in Clinical Trials
Table 2.3. Serine-Threonine Kinase Inhibitors in Clinical Trials for Cancer
Table 2.4. Serine-Threonine Kinase Inhibitors in Clinical Trials for Diseases
Other than Cancer
Table 3.1. Estimated New Cases of Cancer in the United States, Total and
Selected Types
Table 3.2. Sales of Kinase Inhibitors for Cancer, 2004 and 2005
| 
